Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury

Wagenaar, G.T.M.; Laghmani, E.; Visser, Y.P. de; Sengers, R.M.A.; Steendijk, P.; Baelde, H.J.; Walther, F.J. (2013)

Article / Letter to editor

• pulmonary arterial hypertension
• bronchopulmonary dysplasia
• endothelin receptor A antagonist
• nitric oxide synthase inhibition
• right ventricular hypertrophy

• All authors: Wagenaar, G.T.M.; Laghmani, E.; Visser, Y.P. de; Sengers, R.M.A.; Steendijk, P.; Baelde, H.J.; Walther, F.J.
• Date: 2013-02-28
• Journal: AJP - Lung Cellular and Molecular Physiology
• Volume: 304
• Issue: 4
• Pages: L264 - L275
• DOI: doi:10.1152/ajplung.00073.2012